Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Geron Reports Inducement Grants Under Nasdaq Rule 5635(c)(4) For Hires
Geron Corporation announces stock option grants to nine new employees under Nasdaq Listing Rule 5635(c)(4), supporting its blood cancer therapy development.
Sutro's Emerging ADC Pipeline Shows Promising Preclinical Data at AACR
Sutro Biopharma presents promising preclinical data at AACR for STRO-004, STRO-006, and STRO-227, highlighting its emerging high-DAR ADC pipeline progress.
Nuvalent Unveils New Zidesamtinib (NVL-520) Data at AACR 2026 for NSCLC
Nuvalent shares promising clinical data for zidesamtinib (NVL-520) at AACR 2026, targeting heavily pre-treated ROS1-positive NSCLC patients.
FDA Approves Expanded Postoperative Pain Indication for Caldolor Injection
Cumberland Pharmaceuticals secures FDA expanded indication for Caldolor (ibuprofen) injection for postoperative pain management, launching a new HCP website.
Phase 3 EPIC Trial Evaluates NRTX-1001 Cell Therapy for Drug-Resistant MTLE
The Phase 3 EPIC trial evaluates NRTX-1001, an investigational GABAergic cell therapy, as a potential single-administration approach for drug-resistant MTLE.
FDA Accepts Ultragenyx BLA for UX111 Gene Therapy to Treat Sanfilippo
FDA accepts Ultragenyx's BLA for UX111, an investigational AAV9 gene therapy for Sanfilippo syndrome Type A, with a PDUFA action date of September 19.
Zai Lab Reports Promising ZL-1503 Preclinical Data for Atopic Diseases
Zai Lab presented promising preclinical data on ZL-1503, an IL-13 and IL-31Ralpha bispecific antibody, for treating atopic dermatitis at IMMUNOLOGY2026.
FDA Fast Tracks Pevifoscorvir Sodium for Chronic Hepatitis B Treatment
FDA grants fast-track status to Aligos Therapeutics' pevifoscorvir sodium for chronic hepatitis B. Phase 2 trial shows promising interim data.
HiberCell Presents Promising HC-7366 Preclinical Data in ccRCC Models
HiberCell presents preclinical data at AACR 2026 showing HC-7366 combined with VEGFR-TKIs enhances antitumor activity in ccRCC models.
Nasal Spray Reverses Age-Related Brain Inflammation in Preclinical Study
A new nasal spray developed by Texas A&M researchers reverses age-related brain inflammation and restores memory in preclinical models.
Developers Back Alzheimer’s Drugs Despite Report Citing Lack of Efficacy
Eli Lilly and Eisai defend their Alzheimer’s drugs, Kisunla and Leqembi, after a Cochrane review questions the clinical efficacy of anti-amyloid therapies.
Filana Therapeutics Publishes Preclinical Simufilam Data in Epilepsia
Filana Therapeutics publishes preclinical data in Epilepsia showing simufilam attenuates seizure progression in severe TSC-related epilepsy mouse models.
1
2
3
4
5
6
7
8
9
